Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery. [electronic resource]
Producer: 20050726Description: 140-7 p. digitalISSN:- 0300-8126
- Antibiotics, Antineoplastic -- administration & dosage
- Antiretroviral Therapy, Highly Active -- adverse effects
- CD4-Positive T-Lymphocytes -- drug effects
- Doxorubicin -- administration & dosage
- Drug Therapy, Combination
- Female
- HIV Infections -- complications
- HIV-1
- Humans
- Liposomes
- Male
- Remission Induction
- Sarcoma, Kaposi -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.